Task: Answer the MCQ question.
Question: Which drug exhibits a 17.299% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: O=C(Cn1cnc2c(oc3nc4c(cc32)CCCC4)c1=O)Nc1ccccc1
b: CCN(C(=O)CSc1nc2cc(Cl)ccc2c(=O)n1CC(C)C)C1CCS(=O)(=O)C1
Answer: a. O=C(Cn1cnc2c(oc3nc4c(cc32)CCCC4)c1=O)Nc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Cn1cnc2c(oc3nc4c(cc32)CCCC4)c1=O)Nc1ccccc1
O=C(Cn1cnc2c(oc3nc4c(cc32)CCCC4)c1=O)Nc1ccccc1
2-(15-oxo-17-oxa-2,12,14-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),2,8,11(16),12-pentaen-14-yl)-N-phenylacetamide